Furthermore, FGFR2 overexpression is linked to a poor diagnosis and treatment response [33], and its rearrangement or fusion is concentrated in intrahepatic cholangiocarcinoma [34, 35]. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.